President Donald Trump announced that Ukraine and Russia have agreed to stop attacking each other's energy infrastructure, a move he says could help stabilize rising diesel prices caused mainly by the Russia-Ukraine war. Trump made the claim after urging Ukraine to avoid targeting Russian diesel fuel facilities, which he said was causing shortages. While Moscow welcomed the announcement, Ukraine has not confirmed the agreement and maintains that energy sites are legitimate military targets amid ongoing conflict. Diesel prices in the U.S. recently hit $6 per gallon, influenced by the war and tensions in the Middle East affecting oil supply routes.
The announcement by Donald Trump about Ukraine and Russia agreeing not to attack energy targets provides context amid energy market fluctuations. For readers following the energy sector, here is Pluang's market snapshot as of Sep 14, 2026 22:02 WIB: out of 30 priced US energy stocks, 19 rose and 11 fell. Notable movers include Constellation Energy Corporation (CEG) down 6.61% at USD 265.94, Indonesia Energy Corporation Limited (INDO) up 4.23% at USD 3.20, and Uranium Energy Corp (UEC) down 4.21% at USD 10.01.
The Hershey Trust Company sold 1,512 common shares under a trading plan but kept voting control through Class B shares. Hershey will report Q3 earnings on October 29, with investors focused on how price increases affected Halloween-season demand. Q2 ...
W. R. Berkley reported mixed Q3 2026 results with earnings per share of $1.17 beating estimates, but revenue fell short at $3.74 billion versus $3.82 billion expected. The company saw premium growth with gross premiums up 3% and net premiums up 1%, s...
GE Aerospace is set to report its Q3 earnings with analysts forecasting a 21.7% rise in earnings per share to $2.02 and nearly 12% revenue growth to about $12.7 billion. Despite consistently beating estimates, the stock has fallen after past reports ...
Silence Therapeutics' stock surged 125.6% to $19.58 following Merck KGaA's agreement to acquire the RNA-interference drug developer for about $1.3 billion in equity value. Merck will pay $20 per share, a 130% premium over the recent closing price. Ot...
On October 19, 2026, several stocks saw significant declines. Iambic Therapeutics dropped 31.4% but stayed just above its IPO price of $16 after raising $150 million. TCGX Acquisition fell 18.5% following its announcement of a merger with TriGemX Bio...
